| Perspectives on biotechnological halogenation |
2776 Kb |
 |
|
| How green can the industry become with biotechnology? |
6891 Kb |
|
|
| Perspectives on biotechnological halogenation |
890 Kb |
|
|
| Biotechnology through the looking glass |
1404 Kb |
|
|
| Sustainability and Biotechnology |
106 Kb |
|
|
| Swiss Industrial Biocatalysis Consortium (SIBC) |
262 Kb |
|
|
| High temperature and flame retardant cyanate ester resins for aerospace applications |
416 Kb |
|
|
| Tailor-made composite performance properties for high temperature applications |
843 Kb |
|
|
| Structural analysis of arabinogalactan from Larch |
219 Kb |
|
|
| Industrial Biotransformation |
4637 Kb |
|
|
| Novel Aproaches To Improve Composites' Performance In High Temperature And Flame Retardancy Applications |
913 Kb |
|
|
| Biotechnological Manufacturing Options for Organic Chemistry |
176 Kb |
|
|
| Lonza: Biotechnology - A Key Ingredient for success in the Future |
1688 Kb |
|
|
| Dispersive Raman Spectroscopy Utilization |
461 Kb |
|
|
| Peptide purification strategies |
1111 Kb |
|
|
| The Best of Both Worlds - A Case Study in Harnessing Solid- and Liquid-Phase Peptide Synthesis |
2477 Kb |
|
|
| 1,2-Dimethylindole-3-sulfonyl (MIS) as protecting group for the side chain of arginine |
136 Kb |
|
|
| Biotransformations and the Pharma Industry |
10168 Kb |
|
|
| Solid-Phase Synthesis of the Cys-rich Peptide Linaclotide |
481 Kb |
|
|
| Antibody Manufacture: The Search for "Desirable" Cell Lines |
418 Kb |
|
|
| Selection Strategies for Isolating "Desirable" GS-CHO Cell Lines |
470 Kb |
|
|
| Important Topics in the Expression of Recombinant Antibodies from CHO Cells |
1104 Kb |
|
|
| Improving process performance by increasing process robustness |
747 Kb |
|
|
| Improving process performance by increasing process robustness; controlling the physiochemical environment of the culture |
898 Kb |
|
|
| An Emerging Star for Therapeutic and Catalytic Protein Production |
9664 Kb |
|
|
| Process for the preparation of y-butyrolactones |
501 Kb |
|
|
| CarnipureTM in Functional Drinks |
854 Kb |
|
|
| Providing chemists with the right ELN using a custom developed tool |
1940 Kb |
|
|
| Case Study: Successfully Employing a Six Sigma Approach to Reduce IPC Cycle Times |
1196 Kb |
|
|
| High-throughput transfection and engineering of primary cells and cultured cell lines |
604 Kb |
|
|
| UPLC for Synthetic Peptides: A User's Perspective |
1003 Kb |
|
|
| Rapid Production of Antibodies by GS-CHO Pools |
482 Kb |
|
|
| Rapid production of antibodies by pooled CHO transfectants |
415 Kb |
|
|
| ELN as collaborative R&D tool within Lonza's Exclusive Synthesis business |
2762 Kb |
|
|
| L-Carnipure® in Human Nutrition |
823 Kb |
|
|
| Process Development and Production Concepts for the Manufacturing of Organic Fine Chemicals at Lonza |
5911 Kb |
|
|
| Disposables - Breathing new life into existing facilities |
564 Kb |
|
|
| Green Sustainable Chemistry in the Production of Nicotinates |
528 Kb |
|
|
| About concrete, stainless steel and microbes |
441 Kb |
|
|
| Chemocatalysis and Biocatalysis (Biotransformation): some Thoughts of a Chemist and of a Biotechnologist |
3711 Kb |
|
|
| UPLC - Applications for Synthetic Peptides |
759 Kb |
|
|
| Chemocatalysis and Biocatalysis (Biotransformation): Some Thoughts of a Chemist and of a Biotechnologist |
263 Kb |
|
|
| Analysis of phenotypic and genetic parameters in a panel of recombinant antibody expressing GS-CHO cell lines |
240 Kb |
|
|
| About concrete, stainless steel and microbes |
441 Kb |
|
|
| Ligand Tailoring: The First Modular Assembly of Atropisomeric Biarylbisphosphine Ligands |
101 Kb |
|
|
| Engineering CI World Class Initiative |
98 Kb |
|
|
| Cost Beneficial Validation of a Site-Wide Chromatography DataSystem |
90 Kb |
|
|
| Challenges in Industrial Production of Peptides |
976 Kb |
|
|
| Ökonomie und Ökologie im Einklang – nachhaltige chemische Produktion am Beispiel des Lonza-Produktionsverbundes in Visp |
678 Kb |
|
|
| Large Scale Bioprocess for the production of optically pure L-Carnitine |
4429 Kb |
|
|
| Microreactor Technology: A Revolution for the Fine Chemical and Pharmaceutical Industries? |
132 Kb |
|
|
| From the test tube to the 75m3 bioreactor |
602 Kb |
|
|
| Swiss Industrial Biocatalysis Consortium |
2645 Kb |
|
|
| Lonzas BPMSS started cGMP Manufacturing in Sept 04 |
2289 Kb |
|
|
| 100 years of L-Carnitine. L-Carnipure and fatty acid oxidation |
450 Kb |
|
|
| Lonza's SSP for Early Phase Delivery |
401 Kb |
|
|
| Technology development in nicotinate production |
152 Kb |
|
|
| Electrophilic Cyanation and Industrial Application |
255 Kb |
|
|
| An Integrated Approach Combining Reaction Engineering and Design of Experiments for Optimizing Reactions |
106 Kb |
|
|
| Mammalian cell culture: current status, future prospects |
576 Kb |
|
|
| L-Carnitine - The natural choice for functional foods |
241 Kb |
|
|
| L-Carnitine - the ideal supplement for vegetable-based products |
73 Kb |
|
|
| Specific Challenges in Large-Scale Manufacturing of Peptide as API's |
1027 Kb |
|
|
| L-Carnitine for your skin |
70 Kb |
|
|
| The Application of the 2100 Bioanalyzer-Protein chip in the Biotechnology Industry |
475 Kb |
|
|
| Process Development Implications of Biotin Production Scale-Up |
286 Kb |
|
|
| An Emerging Star for Therapeutic and Catalytic Protein Production |
9664 Kb |
|
|
| New non-viral method for gene transfer into primary cells |
1479 Kb |
|
|
| Impurities in Biotechnology Products - Experience of Setting Specifications |
458 Kb |
|
|
| Progress in the Large Scale Production of Monoclonal Antibodies |
483 Kb |
|
|
| Pharmaceutical Custom Manufacturing – Offering challenges |
117 Kb |
|
|
| Pharmaceutical Custom Manufacturing – Offering challenges - Slides |
720 Kb |
|
|
| Industrial Challenges in Fine Chemicals/Biopharmaceuticals |
744 Kb |
|
|
| Optimization and Scale-up of Protein-free Processes for Antibody Production |
242 Kb |
|
|
| Control of Apoptosis in Mammalian Cell Cultures |
781 Kb |
|
|
| Process life cycle in custom manufacturing |
105 Kb |
|
|
| Industrial biocatalysis today and tomorrow |
859 Kb |
|
|
| A Catalytic Green Process for the Production of Niacin |
215 Kb |
|
|
| How green can the industry become with biotechnology? |
6891 Kb |
|
|
